David Bibby is a CEO and Co-founder at Pacalis Therapeutics Pty Ltd. He possess expertise in biotechnology, pharmaceutical industry, drug discovery, clinical trials, drug development and 6 more skills. Colleagues describe him as "David’s team and mine worked closely together for several years to set up serology sample testing at third party laboratories for influenza vaccine clinical trials. I found David to be knowledgeable systematic, resourceful, collaborative and committed. He maintained a consistent focus on quality and technical standards and close attention to budget." and "David and his direct reports in the Clinical Development Operations group at Seqirus were my most significant collaborations while working at Seqrius. David's responsibilities included negotiating contracts with external testing partners for the assays to support vaccine clinical trials and all of the sample logistics to ensure samples made it from the sites to the testing partners. I provided scientific oversight of the work performed at the testing partners. I never had to worry or wonder if a contract would be in place on time. When there were challenges with sample logistics, I knew that David and his team would be relentless in their pursuit to understand the specific issues, resolve them and learn from the experiences. I enjoyed partnering with David on process and scientific improvements related to compliant clinical testing to support late-stage clinical trials. His integrity and commitment to do what is right by the company and the subjects who enrolled in our clinical studies was always evident in everything he did."